Nipple or skin-sparing mastectomy flap: can preoperative breast-MRI predict post-operative complications? - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Can Preoperative Breast MRI Predict Complications After Nipple- or Skin-Sparing Mastectomy?

  • By

  • L. I. Sgaramella

  • A. Pasculli

  • F. P. Prete

  • F. Cofone

  • M. Moschetta

  • M. Maruccia

  • R. Elia

  • M. Telegrafo

  • V. De Ruvo

  • M. Bisceglie

  • M. M. Miccoli

  • F. Palma

  • C. Testini

  • G. Giudice

  • M. Testini

  • A. Gurrado

  • October 13, 2026

Share

  • 1

    This single-center retrospective study assessed whether preoperative MRI flap thickness and demographic characteristics predicted complications after nipple- or skin-sparing mastectomy.

  • 2

    Eligible patients underwent preoperative breast MRI and immediate implant-based, one- or two-stage reconstruction for breast cancer or a BRCA1/2 mutation.

  • 3

    Patients were grouped according to mean preoperative MRI skin-flap thickness below or above 8 mm.

  • 4

    The same experienced surgeons performed all mastectomies, assessing flap viability clinically without routine intraoperative perfusion imaging.

  • 5

    The study aimed to compare early postoperative complications between patients with MRI flap thicknesses below and above 8 mm.

Original Source(s)

Nipple or skin-sparing mastectomy flap: can preoperative breast-MRI predict post-operative complications?

  • by L. I. Sgaramella, A. Pasculli, F. P. Prete, F. Cofone, M. Moschetta, M. Maruccia, R. Elia, M. Telegrafo, V. De Ruvo, M. Bisceglie, M. M. Miccoli, F. Palma, C. Testini, G. Giudice, M. Testini, A. Gurrado

  • October 13, 2026

Related Content

Bringing CAR T Closer to Home

CAR T Vision aims to widen access to cell therapy by expanding community-based delivery, easing operational barriers, and building sustainable funding models

  • October 13, 2026

  • 8 min
Weekly hippocampal diffusion changes during partial-brain radiation therapy for high-grade glioma: associations with dose and early memory change

2026 ASCO Breast Cancer Highlights: persevERA

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the persevERA trial and oral SERDS in metastatic breast cancer.

  • October 15, 2026

  • 1 min